Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05800275
Title Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease (ETIC-LM)
Acronym ETIC-LM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié NOT_YET_RECRUITING Bordeaux 33000 France Details
Centre François Baclesse RECRUITING Caen 14000 France Details
Centre Jean Perrin NOT_YET_RECRUITING Clermont-Ferrand 63011 France Details
Centre Georges-François Leclerc NOT_YET_RECRUITING Dijon 21000 France Details
Centre Léon Bérard RECRUITING Lyon 69008 France Details
Institut régional du Cancer de Montpellier RECRUITING Montpellier 34298 France Details
Centre Antoine Lacassagne NOT_YET_RECRUITING Nice 06189 France Details
Institut Jean Godinot RECRUITING Reims 51100 France Details
Centre Henri Becquerel NOT_YET_RECRUITING Rouen 7600 France Details
Institut de cancérologie Strasbourg Europe - ICANS NOT_YET_RECRUITING Strasbourg 67200 France Details
Gustave Roussy NOT_YET_RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field